|
Unravelling AIDS
What is the real extent of the AIDS epidemic? Why does AIDS attract so
much controversy? Do conventional anti HIV drugs do more harm than good? Are
there safe and effective treatments that can be made widely available at
affordable costs?
This special mini-series is part of an in-depth report, Unravelling
AIDS, to be published by ISIS later this year.
If you are interested in reserving a copy of the full report at a
special prepublication price of £7.50, please e-mail sam@i-sis.org.uk
ISIS Report 01/04/04
Can Traditional Medicine Help AIDS?
While billions of dollars have been pledged to help the worst affected,
many of the poorest countries are still left without the medical support available
in the west, and up to 80% of the population must rely on traditional medicine
for primary healthcare. Sam Burcher reports on some successes
with a native herb.
A fully referenced
version of this report is posted on ISIS
member's website. Full details here
Medicinal plants have been part of the great healing traditions around the
world going back thousands of years; the best known being the Indian Ayurvedic
medical system, Traditional Chinese Medicine and Western Herbal Medicine. These
traditional medicines are the basis of a quarter of all drugs in today’s
modern pharmacy [1].
The World Health Organisation (WHO) defines Traditional Medicine as health
practices, approaches, knowledge and beliefs incorporating plant, animal and
mineral based medicines, spiritual therapies, manual techniques (e.g. reflexology)
applied singularly or in combination to treat, diagnose and prevent illness
or maintain well-being. In 2002 WHO launched its first comprehensive traditional
medicine strategy to assist efforts to promote affordable, effective and safe
use of Traditional Medicine (TM) and Complimentary Alternative Medicine (CAM)
[2].
In Africa, TM is used by up to 80% of the population to meet primary healthcare
needs and is crucial in the fight against infectious diseases. The ratio of
a conventional, or western-trained general practitioner (GP) to patients is
1: 20 000, whereas the availability of TM practitioners is 1: 200 to 1: 400.
This highlights the need for reliable and affordable herbal medicines that are
locally available [3].
In South Africa, it is estimated that over 6 million people are living with
HIV/AIDS and 150 babies are born with HIV every day. Conventional drugs exist
for the treatment of HIV/AIDS, but they are only affordable by an estimated
1% of sufferers. Three out of four AIDS patients in Africa rely on some form
of TM for treating the symptoms of HIV/AIDS (see Box 1).
Sutherlandia Frutescens (subspecies Microphylla) genus Fabaceae (pea
and bean/leguminosae) is a perennial shrub that grows wild in the arid regions
of Botswana, Namibia, Zululand, Western and Eastern Cape regions of Africa.
Sutherlandia can grow up to 1.5 metres in height in optimum conditions of stony
grasslands exposed to constant sunshine in daylight hours. A display of blood
red flowers bloom from June to December and its seeds are carried in greenish-
red papery pods, which are almost transparent. The pinnate and compound shaped
leaves have a green-grey colour giving the bush a silvery appearance [4].
The leaves and branches of the Sutherlandia bush are bitter to the taste,
but are known traditionally to have health-giving properties. The dried leaves,
containing four active compounds, are ground by traditional healers to make
into tonics, teas, pills or creams (see Box 1). In the absence of easily available
and affordable anti-retrovirals, these herbal treatments are used as the first
line of defence in combating the symptoms of AIDS and other wasting diseases.
Traditional Medicine practitioners who prescribe Sutherlandia are keen to preserve
the use of the plant as a traditional medicine to maintain its patent-free status.
Conventional and traditional healers join up
An independent, inter-disciplinary partnership of TM healers, botanists, conventional
doctors and scientists have joined up to form the group, PhytoNova, to prescribe
and record the medicinal benefits of Sutherlandia in the treatment of
HIV/AIDS symptoms. Dr Nigel Gericke, a GP and a botanist and his colleague Mr
Credo Mutwa, 82-year-old traditional healer (sanusi), lead PytoNova's clinical
practice and laboratory in Cape Town, South Africa.
PhytoNova makes and supplies medicinal remedies derived from Sutherlandia
for the treatment of HIV/AIDS symptoms direct to their own patients and
to AIDS clinics in the region before a big pharmaceutical company can get their
hands on it. Hundreds of AIDS patients have been treated by Gericke and Mutwa,
who share the view that as long as they can prove that something is in the public
domain, and is widely used to treat HIV/AIDS, then no one can come along and
patent it for profit.
The price to Africans for a month's supply of pills made from the Sutherlandia
bush is £2.50, and the powder form of the dried leaves, which is thought
to be more effective because of its bitter taste, costs less than 60p for two
month's supply [5].
Gericke describes the promoting of weight gain in wasted, full-blown AIDS patient
as Sutherlandia's principal and most valuable medicinal property. Frequent
significant and often sustainable gains in weight have been recorded in HIV
patients taking Sutherlandia tablets. Weight records of 244 patients receiving
treatment of Sutherlandia between November 1999 and September 2002 are available
from The HIV and AIDS clinic in the Ngwelezane Hospital. Weight increases of
up to15 kg were reported in the majority and in some cases gains of 3-5kgs were
sustained over the entire record keeping period [6]. This physiological boost
has an immediate effect of enhancing energy levels and improving the patient's
mood. Gericke said: "We have seen several examples of bed-ridden patients
able to get up after a month's treatment and even to return to subsistence
farming." Other AIDS patients who were told to "go away and die"
are delighted to find themselves still alive three years on after being treated
by Mutwa. This anecdotal evidence supports the theory that AIDS may have become
a chronic illness rather than a fatal one.
Gericke informed South African government scientists of the benefits of Sutherlandia.
These include improvements in appetite, weight gain, sleep, exercise tolerance,
anxiety and an overall sense of well-being. But "because it was a tonic,
the scientists dismissed it. They always rush, with classical reductionist thinking,
to look for the magic ingredient," said Gericke, summing up the reality
that HIV/AIDS itself is so complex, that it is increasingly apparent that there
is no "one-stop" solution for its treatment. Gericke has also appealed
to his government to grow the bush on a massive scale, to mobilise a public
health drive, but this too was ignored. To protect wildstocks of the plant from
over-harvesting in the region, he has contracted local farmers to grow acres
of Sutherlandia shrubs. This precautionary approach has created local employment
and maintained the "not at risk" status of Sutherlandia as a medicinal
plant.
PhytoNova is convinced that progression to AIDS from HIV can be delayed once
the patient has agreed to receive the appropriate treatment and doses of Sutherlandia,
which are taken on an ongoing basis, in addition to careful attention to diet.
It is recommended that alcohol; recreational drugs and other drugs that damage
the immune system should be avoided. Anne Hutchings, an ethno-botanist and researcher
of traditional Zulu medicine at the University of Zululand, who works in the
weekly HIV and AIDS clinic at Ngwelezane Hospital, supports these prescriptions.
She uses Sutherlandia derived products from PhytoNova in addition to her own
remedies made up from local plants (see box1). She started with just 11 patients
in 1999 and now has more than 400 [5].
In 2001, a community-based AIDS hospice in Emoyeni, South Africa, admitted
71 AIDS patients for terminal care. Sister Pricilla Dlamini treated the patients
with Sutherlandia pills and infusions of another local plant often referred
to as African potato (Hypoxis Hermerocallidea) PhytoNova tracked the progress
of her patients one year later. Of the 71 patients, 30 had been discharged as
healthy back into the community. Some have since returned for follow-up treatments
with Sutherlandia while others have been lost to follow-up treatments. No adverse
events were reported [7].
Virginia Rathele is a nurse and Zulu traditional healer (sangoma) in the Northern
Cape town of Kuruman. She is using Sutherlandia pills to treat 300 AIDS patients
in her clinic. She says "Sutherlandia does not work properly just on a
diet of porridge. You have to have vegetables." One of her patients was
close to death and weighed only 26kg, but after receiving treatment and an improved
diet now weighs 45kg and is helping to run the clinic. Rathele is also keen
to keep the plant patent free and believes the treatment should be accessible
to everyone.
Traditional medicine dispels the darkness
Historically, Sutherlandia has been called many names and used for many purposes.
The indigenous Koi San tribes-people name it "Insiswa" meaning "the
one that dispels darkness." Insiswa has been used for centuries as an
energy booster and anti-depressant. Sangomas know the plant as "unwele",
a "great medicine" which so uplifts your spirit that you will not
want to tear your hair out and was prescribed for the widows of Zulu warriors.
The name "cancer bush" or "kankerbos" is another name
ascribed to Sutherlandia by Afrikaners and attests to a traditional use as a
cancer remedy. Sutherlandia came to the attention of British botanists when
Zulu sangomas used it against the 1918 influenza pandemic that killed 20 million
worldwide. The English version of Sutherlandia was named after James Sutherland,
the first superintendent of the Edinburgh Botantical Gardens [8].
Sutherlandia has a "beautiful portfolio of chemicals" says Gericke
(see Box 2). He has analysed and identified a range of chemicals, which have
been previously used for the treatment of patients with cancer, TB diabetes,
schizophrenia and depression and as an anti-retroviral agent. Some of these
molecules, already identified from sources other than Sutherlandia have US patents
attached to them for their use in treatment of these diseases [9]. Gericke recognises
the great potential of the plant's chemistry and says: "The claim
we are making on the basis of this, is that we can dramatically improve the
quality of life of many AIDS patients. We are certainly not making the absurd
claim that Sutherlandia is a cure-all or a cure for AIDS.
The medical records of a patient who had ceased taking conventional anti-retrovirals
to combat symptoms of HIV /AIDS for two years before turning to PhytoNova for
treatments using Sutherlandia pills were documented. These show a marked decrease
in the patient's viral load and a significant increase of his CD4 lymphocyte
cell count over a six-week period. His starting CD4 count in May 2001 was 340,
which increased to 647 in June 2001. During the same period his viral load decreased
from 25 000 to 9 200 [10].
A study on toxicity
To date, no severe adverse reactions to Sutherlandia in any form has ever been
reported. Nevertheless an independent safety study was conducted by South Africa's
Medical Research Council because of the significant ethno-botanical background
and availability of the plant as well as the severity of the HIV/AIDS problem
in the region. The study tested the effect of Sutherlandia on sixteen vervet
monkeys in four groups including one control. The monkeys were fed with dried
Sutherlandia leaf powder for three months and exhibited no single indication
of toxicity even in the group fed nine times the dose prescribed for the treatment
of AIDS in humans. A massive dose of 1x 500mg/kg by mouth was administered without
any adverse effect. This is the first South African medicinal plant to be evaluated
for toxicity using primates in a controlled study [11].
The Indigenous Knowledge Systems Division (IKS) of The MRC in South Africa
is committed to the scientific and clinical validation of promising indigenous
medicinal plants. Sutherlandia is considered by IKS to have a long history of
medicinal use going back at least 105 years. It acknowledges that a tonic made
from the plants may be of value to people living with HIV/AIDS in terms of enhanced
well being, increased appetite and body mass as well as increased tolerance
for exercise. Use of Sutherlandia is contraindicated in pregnancy [12].
The IKS was formed in 2001, and has created successful collaborations with
traditional healers across the regions of Africa. So far they have identified
20 traditional healers across the region from the 300 000 that are estimated
to exist on the continent. The select healers are encouraged to keep records
of their consultations and it is hoped they will train other healers to do so.
A medicinal garden project has also been started where plants can be cultivated
and identified. A library and computers systems are also being developed alongside
a TM database called TRAMED III, which incorporates medicinal plant monographs.
Not all testimonies to the powers of Sutherlandia are glowing. Stuart Thomson,
director of Gaia Research has attacked the plant, the MRC trials and PhytoNova.
He says Sutherlandia is a "poison panacea" and PhytoNova is unlawfully
distributing a substance, which he believes is potentially toxic as well as
using people as human guinea pigs. Thomson considers the MRC study to be invalid
because the monkeys were not infected with HIV/AIDS and were studied for less
than six months [13]. He also raises some questions on the safety of L-Canavanine
(see box 2). But Sutherlandia taken under allopathic or traditional medical
guidance would certainly seem to offer an alternative to sludgy liquids made
of industrial solvents which sell on the streets of Johannesburg like hot cakes
by those looking to exploit the numbers of desperate people living with HIV
/AIDS [14].
Of course, there are plants among Africa's flora and fauna that are toxic
and efforts are being made to study and document these to avoid incorrect TM
treatment of HIV/AIDS or indeed any illness. One such plant recorded to have
toxic properties is Callilepis Laurealo or "Impila".
One Sutherlandia plant can treat ten people
Mutwa of PhytoNova says cultivating Sutherlandia is a question of sanding each
little seed with fine sandpaper; planting, watering and letting them grow. He
refuses to see his country destroyed by HIV and AIDS when nobody really knows
the origins of the disease. His reminds critics that the bark of the Cinchona
tree forms the natural chemical basis of quinine which, when used correctly
is a successful treatment of Malaria for many [15]. Since resistance to quinine
has become more prevalent, the shrub Artemesia was discovered to contain Artemisian,
an alkaloid with even great efficacy for the treatment of mefloquinine resistant
strains of Malaria.
The MRC also plans a pilot clinical trial involving 50 people on the medicinal
effects of Sutherlandia [16]. This was scheduled to begin in February 2002,
pending a decision by the Governments Medical Approval Council. The Director
of the IKS Dr Matlalepula Matsabisa told the New Scientist "A trial like
this could act as a valuable template for other trials." He said [17],
"The fact is people are already using it and will continue to whether
or not the government approves trials." It appears that Africa's
first line treatment of HIV /AIDS is Sutherlandia, local to the regions where
it is needed the most, whose history as a beneficial, though bitter, Traditional
Medicine puts it firmly in the hands of the people.
Box 1
| Primary
symptoms reported byHIV+ and AIDS Patients in Ngwelezane Hospital. |
Oral
and topical Traditional Medicines Prescribed to combat the primary symptoms
of HIV and AIDS at Ngwelezne Hospital. |
| Cough,
cold, bronchitis |
Lippia
javanica (umsuzwane) fresh leaves to make tea infusion. |
| Chest
pain |
Warburgia
salutaris (isibaha) two fresh leaves in tea infusion. Contraindicated
in pregnancy. |
| Diarrhoea |
Psidium
guajava (guava) two crushed leaves with plenty of liquid. Discontinue
when symptoms subside. |
| Itchy,
painful rashes, |
Centella
asiatica (pennywort) fresh leaves blended with glycerine to make a
cream. |
| Headaches,
shortness of breath |
Artemisia
afra (umhylonyane) fresh aromatic leaves inhaled from a gauze bag
to ease symptoms. |
| Loss of
Energy, weakness, |
Hypoxis
hemerocallidea (inkomfe). Weak infusions made from the corms of the
African potato make an excellent strengthening tonic, but must be used
under medical supervision. |
| Loss of
weight/appetite |
Sutherlandia
(unwele) tablets from dried leaves. One 300mg twice a day with meals (half
dose for child) |
| Oral sores,
body sores, swelling, |
Bulibine
frutescens (ibhucu) sap from leaves, applied directly or in a cream. |
| Throat
infections |
Siphononchilus
aethiopicus (African ginger (indungulu) Tablets made from the Rhizomes
derived from fresh roots. |
*Secondary symptoms reported by patients at Ngwelezane Clinic: abdominal pain,
night sweats/fevers, urinary problems, nausea/vomiting and swollen glands. All
the above recommended TM treatments were made by healthcare professionals at
an HIV/AIDS clinic in South Africa .
Box 2
Medicinal Compounds isolated from the leaves of Sutherlandia frutescens
(subspecies microphylla>)
L-Canavanine is a potent non-protein amino acid, l-arginine antagonist
with documented anti-viral, anti-bacterial, anti-fungal and anti-cancer
activities. L-canavanvine has patented anti-viral activity against influenza
and retrovirus, including HIV. A US patent registered in 1988 claims
selective destruction of 95% HIV infected lymphocytes in vitro.
Pinitol is a known anti-diabetic agent, described in its 1996 patent
as having some benefits in the clinical application of treating wasting
in cancer and HIV/AIDS.
GABA is an inhibitory neurotransmitter. This could account for
Sutherlandia's success in treating anxiety, stress and depression
and for observed improvements in mood and well being experienced by
patients taking preparations from the plant
SU1 is a novel triterpenoid isolated by members of the Phyto
Nova team, which is showing promising biological activity
|
| |
|